The STEP (safety and toxicity of excipients for paediatrics) database. Part 1 - A need assessment study

International Journal of Pharmaceutics

Volumn 435, Issue 2, 2012, Pages 101-111

  Salunke, Smita ^a,b   Giacoia, George ^c   Tuleu, Catherine ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b European Paediatric Formulation Initiative ^*  (United Kingdom)

^c Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)   (United Kingdom)

Author keywords

Adverse effects; EuPFI; Excipients; Paediatrics; Safety; STEP database; Toxicity; US PFI

Indexed keywords

EXCIPIENT;

CONFERENCE PAPER; DATA BASE; DRUG FORMULATION; DRUG INFORMATION; DRUG MANUFACTURE; DRUG SAFETY; E-MAIL; HEALTH SURVEY; INTERNET; MEDICAL INFORMATION SYSTEM; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY AND TOXICITY OF EXCIPIENTS FOR PAEDIATRICS DATABASE; TOXICOLOGY;

CHILD; DATABASES, FACTUAL; DRUG TOXICITY; EXCIPIENTS; HUMANS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES;

EID: 84864666274     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.05.004     Document Type: Conference Paper

References (30)

1. D.A. Adkin, S.S. Davis, R.A. Sparrow, P.D. Huckle, A.J. Phillips, and I.R. Wilding The effect of different concentrations of mannitol in solution on small intestinal transit: implications for drug absorption Pharm. Res. 12 1995 393 396
2. P. Baldrick Pharmaceutical excipient development: the need for preclinical guidance Regul. Toxicol. Pharmacol. 32 2000 210 218
3. K. Briggs, M. Cases, D.J. Heard, M. Pastor, F. Pognan, F. Sanz, C.H. Schwab, T. Steger-Hartmann, A. Sutter, D.K. Watson, and J.D. Wichard Inroads to predict in vivo toxicology - an introduction to the eTOX project Int. J. Mol. Sci. 13 3 2012 3820 3846
4. Distributed Structure-Searchable Toxicity (DSSTox) Database Network. Available from: http://www.epa.gov/ncct/dsstox/index.html (accessed 12.04.12).
5. ECB QSAR Model Reporting Format (QMRF). Available from: http://ihcp.jrc.ec.europa.eu/our
6. EMA, 2008. Guideline on the need for nonclinical testing in juvenile animals on human pharmaceuticals for paediatric indications. Committee for Human Medicinal Products (CHMP). EMEA/CHMP/SWP/169215/2005. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003305.pdf (accessed 14.02.12).
7. EMA, 2007. Guideline on excipients in the dossier for application for marketing authorisation of a medicinal product. Committee for Medicinal Products for Human Use (CHMP) EMEA/CHMP/QWP/396951/2006. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003382.pdf (accessed 14.02.12).
8. European Commission, 1975. Council Directive 75/318/EEC. Official Journal of the European Communities. Available from: http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=OJ:L: 1975:147:0001:0012:EN:PDF. (accessed 14.02.12).
9. V. Fabiano, C. Mameli, and G.V. Zuccotti Paediatric pharmacology: remember the excipients Pharmacol. Res. 63 2011 362 365
10. FDA, 2005. Guidance for Industry: Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients. http://www.fda.gov/ohrms/dockets/98fr/ 2002d-0389-gdl0002.pdf (accessed 06.02.12).
11. FDA, 2006. Guidance Document. Nonclinical safety evaluation of pediatric drug products. Available from: http://www.fda.gov/ohrms/dockets/98fr/03d-0001- gdl002.pdf. (accessed 06.02.12).
12. FDA, 2011. Drug Safety Communication: Serious health problems seen in premature babies given Kaletra (lopinavir/ritonavir) oral solution. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm246002.htm (accessed 06.02.12).
13. FDA, 1996. Centre for Drug Evaluation and Research. Inactive ingredient search for approved drug products. Available from: http://www.accessdata.fda. gov/scripts/cder/iig/index.cfm (accessed 13.02.12).
14. Hazardous Substances Data Bank (HSDB), (US) National Library of Medicine, Available from: http://toxnet.nlm.nih.gov/ (accessed 12.04.12).
15. International Chemical Identifier InChI. Available from: http://inchi.info/ (accessed 12.04.12).
16. IPEC, 1997. The proposed guidelines for the safety evaluation of new excipients, The IPEC Europe Safety Committee. Eur. Pharm. Rev. 13-30.
17. JPEC Japanese Pharmaceutical Excipient Directory 1996 Yakuji Nippon Ltd. Tokyo
18. H.-J. Klimisch, M. Andrear, and U. Tillmann A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data Reg. Toxicol. Pharmacol. 25 1997 1 5
19. Leadscope's ToXML schema. Available from: http://www.leadscope.com/toxml. php (accessed 12.04.12).
20. R. Mason What is an information professional? J. Educ. LibrInf. Sci. 31 1990 122 138
21. NTP, National Toxicology Program database. Available from: http://ntp-apps.niehs.nih.gov/ntp-tox/index.cfm# (accessed 14.02.12).
22. V. Patel, T. Desai, B. Chavda, and R. Katira Extemporaneous dosage form for oral liquids Pharmacophore 2 2011 86 103
23. G. Pifferi, and P. Restani The safety of pharmaceutical excipients Il Farmaco 58 2003 541 550
24. Pubchem. Available from: http://pubchem.ncbi.nlm.nih.gov/ (accessed 12.02.12).
25. R.C. Rowe, P. Sheskey, and P.J. Weller Handbook of Pharmaceutical Excipients 4th ed. 2003 American Pharmaceutical Association and The Pharmaceutical Press
26. M. Steinberg, J. Borzelleca, E.K. Enters, F.K. Kinoshita, A. Loper, D.B. Mitchell, C.B. Tamulinas, and M.L. Weiner A new approach to the safety assessment of pharmaceutical excipients The Safety Committee of the International Pharmaceutical Excipients Council Regul. Toxicol. Pharmacol. 24 1996 149 154
27. M. Uchiyama Regulatory status of excipients in Japan Drug Inform. J. 33 1999 27 32
28. USP, 24-NF 19 General Chapter 1074 Excipient Biological Safety Evaluation Guidelines 2000 United States Pharmacopoeial Convention Rockville, MD pp. 2037-2040
29. Vitic Nexus - Interrogation of existing data for toxicity assessment. Available from: https://www.lhasalimited.org/library/item/vitic-nexus- interrogation-of-existing-data-for-toxicity-assessment / (accessed 12.02.12).
30. A. Whittaker, A. Currie, M.A. Turner, D.J. Field, H. Mulla, and H.C. Pandya Toxic additives in medication for preterm infants Arch. Disease Childhood Fetal Neonatal Ed. 94 2009 F236 F240